Researchers Mapped Protein Transport Mechanism
Scientists identified how MFSD2B exports sphingosine-1-phosphate from blood cells into the bloodstream.
Updated on Sept. 21, 2026 in Life Sciences
Live Poll
Do you believe new discoveries in cell biology will lead to effective medical treatments?
Researchers have successfully mapped the atomic structure and transport mechanism of the MFSD2B protein found in red blood cells and platelets. This protein acts as the primary conduit for moving sphingosine-1-phosphate into the bloodstream based on concentration gradients.
Why it matters
Proper transport of sphingosine-1-phosphate is vital for maintaining blood pressure and preventing vascular damage. Identifying this mechanism offers potential new pathways for therapeutic interventions.
Researchers utilized cryo-electron microscopy to visualize the MFSD2B protein at the atomic level, revealing how it uses amino acids K88 and K423 to guide molecules. The study confirmed that transport relies on concentration gradients rather than external energy.
The players
NUS Medicine
This academic medical center in Singapore served as a co-lead research institution for the study.
St. Jude Children's Research Hospital
Based in the United States, this institution acted as a co-lead in the collaborative structural research.
The details
By combining structural imaging with computer simulations, the team determined that the protein functions as a passive transporter moving sphingosine-1-phosphate from high-concentration areas in red blood cells to lower concentrations in plasma. Engineering a change to a single amino acid was shown to fundamentally alter the functional requirements of the transporter.
Timeline
Researchers first discovered the MFSD2B protein 10 years ago.
The findings were published in Nature Communications on September 21, 2026.
The Big Picture
This study advances the ongoing characterization of the MFSD2B protein family by providing the first atomic-level understanding of its transport path. The discovery shifts the theoretical understanding of blood cell function by proving that this specific transport relies on passive diffusion gradients.
The identification of this mechanism is currently focused on laboratory research rather than immediate clinical use. However, future developments in compounds that block MFSD2B could eventually lead to new medical treatments for vascular damage and hypertension.
The takeaway
This discovery demystifies how blood cells maintain the balance of essential signaling molecules within the circulatory system. Researchers are now prioritizing the development of compounds that can modulate this protein to manage blood-pressure-related health conditions.
Further reading
For more context on recent breakthroughs, visit the Life Sciences section.
Source note: This article includes information reported by Technology Networks.
Live Poll
Do you believe new discoveries in cell biology will lead to effective medical treatments?
